FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11398611000001108: Betahistine 16mg tablets (Pliva Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40714901000001118 Betahistine 16mg tablets (Pliva Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42064901000001113 Betahistine 16mg tablets (PLIVA Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betahistine 16mg tablets (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Is a Betahistine 16mg tablets true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Is a Betahistine 16mg tablets false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Is a Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Has active ingredient Betahistine dihydrochloride false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Has active ingredient Betahistine false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Has specific active ingredient Betahistine dihydrochloride true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Betahistine 16mg tablets (Pliva Pharma Ltd) 84 tablet 7 x 12 tablets Is pack of False Betahistine 16mg tablets (Pliva Pharma Ltd) Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Pliva Pharma Ltd) 84 tablet 7 x 12 tablets Has AMP True Betahistine 16mg tablets (Pliva Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start